Navigation Links
Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
Date:3/9/2009

ompany's common stock.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: There can be no assurance that the Company will satisfy Nasdaq's conditions for continued listing on The Nasdaq Capital Market, that any potential appeal or hearing for a stay of delisting from The Nasdaq Capital Market will be successful, or that the Company
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
5. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
9. FDA Struggles to Keep Pace With Requests for Generics
10. President Bush Requests Funding Cuts That Endanger Domestic Violence Victims
11. Maryland Stem Cell Commission Issues Requests for Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... treatments for injuries and damage to the joints, including ... is a hard material that caps the ends of ... biomedical engineers, exploring ways to toughen up engineered cartilage ... new developments this week in the journal Proceedings ... problem with engineered tissue is that the mechanical properties ...
(Date:10/30/2014)... Nutrition Leaders, a popular online retailer ... and more, is currently hosting a sweepstakes on its ... is open to U.S. residents age 18 and over, ... One lucky winner will then be selected at random ... card to NutritionLeaders.com. , Nutrition Leaders’ managing director Kimba ...
(Date:10/30/2014)... Portland, OR (PRWEB) October 30, 2014 ... law firm Hodgkinson Street LLC announces new branding ... Hodgkinson Street Mepham . After David Mepham’s promotion ... revitalizes their brand and website to include Mepham’s name ... leading medical malpractice and mediation firm, the decision to ...
(Date:10/30/2014)... Tara Haelle ... News) -- More than 100 genes have been identified ... studies report. And researchers say they are on ... that may contribute to the disorder. Autism spectrum ... communication and social difficulties and repetitive behaviors. An estimated ...
(Date:10/30/2014)... 30, 2014 Global prebiotics market is ... to a new study by Grand View Research, Inc. ... for sugar and fat free products owing to increased ... for prebiotics over the forecast period. , View full ... Food & beverage was the largest application segment with ...
Breaking Medicine News(10 mins):Health News:Making lab-grown tissues stronger 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Hodgkinson Street Mepham Rebrands 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5
... a dangerous heart arrhythmia, study finds , THURSDAY, Dec. ... rapid heartbeat called ventricular tachycardia often get implantable cardiac ... study suggests that they will have fewer recurrences of ... ablation before they receive the device. , Reporting Dec. ...
... , REDMOND, Wash., Dec. 31 It,s a fact: each ... from concerned family members looking for help and answers as to ... assistance. The surge comes post holiday, a time when adult children ... parents and family members. Aegis Living, a national leader in senior ...
... genetic puzzle to try to save the mammals , THURSDAY, ... understanding of an outbreak of cancerous tumors that is killing ... , Devil facial tumor disease, a kind of cancer that,s ... contact, is one of only two types of cancer known ...
... , , WESTON, Fla., Dec. ... (the Company) annual meeting of shareholders on December 28, 2009 ... As there were not sufficient shares present in person or by ... Meeting, the Company adjourned the Annual Meeting in order to permit ...
... boom could strain resources with not just more but sicker ... getting older, and experts say the nation,s health-care system is ... The oldest members of the 78-million-strong baby-boom generation are about ... proportion of U.S. residents older than 65 will double, according ...
... , MISSION, Kan., ... subsidy extension into law on Dec. 19, 2009. With this extension, ... and adjust administrative procedures. To smooth the transition, COBRAGuard Inc. is ... Central Time. The Webinar is entitled, "How to Get it Right ...
Cached Medicine News:Health News:Procedure Boosts Outcomes in Implantable Defibrillator Patients 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 3Health News:Clues to Cancer That Could Wipe Out Tasmanian Devils 2Health News:American Scientific Resources 2009 Annual Meeting of Shareholders Adjourned 2Health News:As U.S. Ages, Health Care May Need to Change 2Health News:As U.S. Ages, Health Care May Need to Change 3Health News:COBRAGuard Offers Free Action Plan Webinar to Assist Employers with COBRA Subsidy Extension 2Health News:COBRAGuard Offers Free Action Plan Webinar to Assist Employers with COBRA Subsidy Extension 3
(Date:10/30/2014)... Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic instruments for ... that it will report financial results for the first ... The Company has scheduled a conference call that same ... to review the results. Interested parties ...
(Date:10/30/2014)... , Oct. 30, 2014 Boston Scientific ... participate in the 2014 Credit Suisse Annual Healthcare Conference ... , AZ.  Dan Brennan , executive vice ... about the company beginning at approximately 8:00 a.m. PT ... A live webcast of the presentation and question and ...
(Date:10/30/2014)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 30, 2014 on Thursday, November 6, 2014, after the ... president and chief executive officer, will host a conference ... Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... of the conference call can be accessed through a ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Boston Scientific To Participate In 2014 Credit Suisse Annual Healthcare Conference 2Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
... Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... leading China-based biotechnology company focused on researching, developing, ... the annual general meeting of shareholders of 3SBio ... at 10:00 a.m., Shenyang time, at our executive ...
... As Medicare expands a controversial "competitive" bidding program for home ... Congress have gone on record to oppose that program citing ... and impact on local jobs. "There,s a reason ... 244 economists and auction experts , and 145 members ...
Cached Medicine Technology:3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 2Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 3Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 4Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: